Jean‐pierre Revillard

Jean‐pierre Revillard's AcademicInfluence.com Rankings

Biology

#10355

World Rank

#13681

Historical Rank

Immunology

#646

World Rank

#667

Historical Rank

biology Degrees

Download Badge

Biology

Jean‐pierre Revillard's Degrees

PhD Immunology Université Paris Cité

Why Is Jean‐pierre Revillard Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jean‐pierre Revillard's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. (1998) (430)
Mechanisms of action of methotrexate. (2000) (349)
Major histocompatibility complex class I‐restricted CD8+ T cells and class II‐restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene (1995) (315)
Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. (1983) (310)
MECHANISMS INVOLVED IN ANTITHYMOCYTE GLOBULIN IMMUNOSUPPRESSIVE ACTIVITY IN A NONHUMAN PRIMATE MODEL 1 (2001) (282)
Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis. (1995) (223)
Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. (1998) (220)
Murine enterocytes can present soluble antigen to specific class II‐restricted CD4+ T cells (1989) (220)
Differential Control of Cell Cycle, Proliferation, and Survival of Primary T Lymphocytes by Purine and Pyrimidine Nucleotides1 (2003) (202)
Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. (1991) (201)
Clinicopathologic features of graft rejection of the first human hand allograft (2003) (200)
The animal lectin galectin-3 interacts with bacterial lipopolysaccharides via two independent sites. (1996) (168)
Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. (1996) (145)
CD4 antibody treatment of severe psoriasis (1991) (139)
Serum β2-Microglobulin in Hemodialyzed Patients (1978) (136)
Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins1 (2003) (132)
Expression, function and regulation of the intercellular adhesion molecule‐1 (ICAM‐1) on human intestinal epithelial cell lines (1991) (119)
The Clinical Usefulness of the Measurement of Cytokines (2000) (109)
Proteins in normal and pathological urine (1970) (106)
Anti-CD4 monoclonal antibody therapy in severe psoriasis. (1992) (106)
T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency. (1975) (101)
Caspase-Independent Phosphatidylserine Exposure During Apoptosis of Primary T Lymphocytes1 (2002) (100)
First human hand transplantation (2000) (95)
Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis. (1996) (89)
Distribution of androgen and estrogen receptors among lymphoid and haemopoietic cell lines. (1985) (88)
Caspase-dependent Ceramide Production in Fas- and HLA Class I-mediated Peripheral T Cell Apoptosis* (1998) (79)
Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion. (2003) (78)
Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients. (1991) (74)
Cathepsin-Dependent Apoptosis Triggered by Supraoptimal Activation of T Lymphocytes: A Possible Mechanism of High Dose Tolerance1 (2004) (69)
Mycophenolic Acid Inhibits IL-2-Dependent T Cell Proliferation, But Not IL-2-Dependent Survival and Sensitization to Apoptosis1 (2002) (68)
The phosphoprotein phosphatase calcineurin controls calcium‐dependent apoptosis in B cell lines (1994) (68)
The topoisomerase inhibitors camptothecin and etoposide induce a CD95-independent apoptosis of activated peripheral lymphocytes (2000) (65)
Anthracyclines trigger apoptosis of both G0 G1 and cycling peripheral blood lymphocytes and induce massive deletion of mature T and B cells (1999) (65)
Activated lung lymphocytes in hypersensitivity pneumonitis. (1984) (65)
Distribution of Cells Binding Erythrocyte‐Antibody (EA) Complexes in Human Lymphoid Populations (1976) (63)
First human double hand transplantation: efficacy of a conventional immunosuppressive protocol (2003) (63)
Transfer factor therapy in immuno-deficiencies. (1973) (58)
Lipid peroxidation in human immunodeficiency virus infection. (1992) (58)
A1/Bfl-1 expression is restricted to TCR engagement in T lymphocytes (2003) (57)
Kinetics of 125I-β2-microglobulin turnover in dialyzed patients (1992) (56)
Apoptosis induced by polyclonal antilymphocyte globulins in human B-cell lines. (1994) (55)
Changes of Fcgamma receptor-related properties induced by interaction of human lymphocytes with insoluble immune complexes. (1977) (55)
Anti-β2-Microglobulin Lymphocytotoxic Autoantibodies in Systemic Lupus Erythematosus (1979) (53)
Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells. (1993) (53)
Apoptosis without decrease of cell DNA content (1995) (53)
Estrogen and progesterone receptors in some human myeloma cell lines and murine hybridomas. (1988) (52)
Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis. (1994) (50)
Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I alpha1 domain. (1997) (48)
Anti-CD4 monoclonal antibody administration in renal transplanted patients. (1990) (48)
A human T-independent B lymphocyte mitogen extracted from Nocardia opaca. (1976) (47)
Antibody-dependent cell cytoxicity (ADCC). Characterization of 'killer' cells in human lymphoid organs. (1976) (44)
Antiproliferative effect of antilymphocyte globulins on B cells and B-cell lines. (1992) (44)
Renal tubular absorption of β2 microglobulin (1984) (44)
Opposite effects of the catecholamines dopamine and norepinephrine on murine polyclonal B-cell activation. (1988) (43)
Characterization of calcitonin gene-related peptide receptors and adenylate cyclase response in the murine macrophage cell line P388 D1 (1991) (43)
Inhibition of the mixed lymphocyte reaction by sera from multipara. (2008) (41)
Enumeration of CR1 complement receptors on erythrocytes using a new method for detecting low density cell surface antigens by flow cytometry. (1987) (41)
Elevation of serum β2 microglobulin in liver diseases (1981) (41)
Treatment of severe Crohn's disease with anti‐CD4 monoclonal antibody (1996) (39)
APOPTOSIS OF SUPERANTIGEN-ACTIVATED T CELLS INDUCED BY MYCOPHENOLATE MOFETIL TREATMENT1 (2001) (39)
Cyclosporin A and FK506 inhibit activation-induced cell death in the murine WEHI-231 B cell line. (1994) (38)
Differential regulation of mouse B-cell activation by beta-adrenoceptor stimulation depending on type of mitogens. (1990) (37)
Plasma β2, Microglobulin Turnover in Renal Insufficiency (1980) (37)
Inhibition of CD25 (IL-2R alpha) expression and T-cell proliferation by polyclonal anti-thymocyte globulins. (1992) (36)
Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro. (1988) (36)
Restriction of De Novo Nucleotide Biosynthesis Interferes with Clonal Expansion and Differentiation into Effector and Memory CD8 T Cells12 (2004) (36)
Organ Shortage: The Solutions (1995) (36)
β2-MICROGLOBULIN-ASSOCIATED AMYLOIDOSIS IN CHRONIC HAEMODIALYSIS PATIENTS (1986) (35)
B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation. (1987) (34)
Beta-2-microglobulin and HLA-related glycoproteins in human urine and serum. (1981) (34)
Structure and metabolism of beta-2-microglobulin. (1988) (34)
A quantitative flow cytometry assay for the preclinical testing and pharmacological monitoring of rabbit antilymphocyte globulins (rATG). (2000) (33)
Tumor necrosis factor-α up-regulates Bcl-2 expression and decreases calcium-dependent apoptosis in human B cell lines (1995) (33)
Suppression of mitogen‐induced peripheral B cell differentiation by soluble Fcγ receptors released from lymphocytes (1980) (33)
Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in murine popliteal lymph node (PLN) test. (1992) (33)
Selective suppression of human B lymphocyte differentiation into IgG-producing cells by soluble Fc gamma receptors. (1982) (32)
Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera. (1976) (32)
[Proteinuria in renal tubular disorders]. (1966) (32)
The effect of anti-CD4 monoclonal antibody treatment on immunopathological changes in psoriatic skin. (1994) (31)
Activation-dependent lymphocyte apoptosis induced by methotrexate. (1998) (31)
Elevation of serum β2-microglobulin levels during infectious mononucleosis (1982) (30)
Flow cytometry analysis of T lymphocytes in sarcoidosis. (1982) (30)
Apoptosis: potential for disease therapies. (1998) (29)
First human hand transplantation (2000) (29)
T-dependence of human B lymphocyte proliferative response to mitogens. (1976) (29)
Selective T cell defects induced by dopamine administration in mice. (1987) (28)
Stimulation of human B lymphocytes by Nocardia-delipidated cell mitogen and derived fractions from N. opaca. Structure-activity relationship. (1985) (28)
Flow cytometry study of cytokeratin 18 expression according to tumor grade and deoxyribonucleic acid content in human bladder tumors. (1989) (28)
Blocking antibodies eluted from human placenta. (1973) (27)
Study of human T and B lymphocytes with heterologous antisera. III. Immunofluorescence studies on tonsil sections. (1978) (27)
Comparison of radio-immunoassay and lymphocytotoxicity inhibition techniques for the determination of beta2 microglobulin. (1976) (27)
Profound CD4+ lymphocytopenia in the absence of HIV infection in a patient with visceral leishmaniasis. (1990) (27)
In vivo effects of monoclonal antibodies against rat beta(2) integrins on kidney ischemia-reperfusion injury. (1999) (27)
Presence of estrogen binding sites and growth-stimulating effect of estradiol in the human myelogenous cell line HL60. (1982) (27)
Beta 2-microglobulin metabolism in uremic patients who are undergoing dialysis. (1993) (26)
A sandwich method of enzyme immunoassay. III. Assay for human beta-2 microglobulin compared with radioimmunoassay. (1980) (26)
Detection of virus-specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection by enzymeimmuno and radioimmunoassay techniques. (1982) (26)
Antibodies to HLA class I alpha1 domain trigger apoptosis of CD40-activated human B lymphocytes. (1997) (26)
Inhibition of the mixed lymphocyte reaction by antibodies. (1972) (26)
Sandwich-type ELISA for free and bound secretory component in human biological fluids. (1988) (25)
Serum secretory IgA and secretory component in patients with non-cirrhotic alcoholic liver diseases. (1995) (24)
CD14 and CD11b mediate serum-independent binding to human monocytes of an acylpolygalactoside isolated from Klebsiella pneumoniae (1994) (23)
T cell sensitivity to HLA class I‐mediated apoptosis is dependent on interleukin‐2 and interleukin‐4 (1997) (23)
Inhibition of mixed lymphocyte culture by alloantibodies in renal transplantation and in pregnancy. (1973) (22)
Detection of specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection. (1981) (22)
Anti-HLA-DR alloantibodies eluted from human placental tissue. (1979) (22)
Insoluble immune complexes suppress mitogen-induced proliferation of human T lymphocytes bearing Fc gamma receptors. (1979) (22)
Down-regulation of cell surface CD4 molecule expression induced by anti-CD4 antibodies in human T lymphocytes. (1992) (22)
beta 2-Microglobulin and beta 2-microglobulin-binding proteins in inflammatory diseases. (1982) (22)
Binding of a membrane proteoglycan from Klebsiella pneumoniae and its derivatives to human leukocytes. (1992) (22)
Inhibition of thymidine synthesis by folate analogues induces a Fas-Fas ligand-independent deletion of superantigen-reactive peripheral T cells. (2001) (21)
DNA ploidy status and DNA content instability within single tumors in renal cell carcinoma. (1993) (21)
Down-regulation of lymphocyte CD4 antigen expression by administration of anti-CD4 monoclonal antibody. (1992) (21)
Experimental models and mechanisms of immune deficiencies of nutritional origin. (1990) (21)
Detection of human papillomavirus DNA in CaSki and HeLa cells by fluorescent in situ hybridization. Analysis by flow cytometry and confocal laser scanning microscopy. (1993) (21)
Suppression of the late stages of mitogen-induced human B cell differentiation by FC gamma receptors (FC gamma R) released from polymorphonuclear neutrophils. (1981) (21)
Impaired T-dependent immune response in L-dopa treated BALB/c mice. (1987) (21)
Presence of “la‐like” antigens on human T lymphocytes bearing receptors for IgG (1977) (20)
Increased DNA and/or RNA content of synovial fluid cells in rheumatoid arthritis: a flow-cytometry study. (1984) (20)
Polyclonal activation of murine B cells by a membrane proteoglycan of Klebsiella pneumoniae. (1987) (20)
Elevated serum beta 2-microglobulin levels and C1q-binding immune complexes in sarcoidosis. (1979) (20)
Molecular variants of beta 2-microglobulin in renal insufficiency. (1994) (20)
The binding of beta-2-microglobulin to renal brush-border membrane: affinity measurement, inhibition by serum albumin. (1988) (20)
The suppressive activity of Fcγ receptors is not related to their T-cell origin☆ (1982) (19)
Binding of alpha 1 antitrypsin (α1 protease inhibitor) to human lymphocytes (1981) (19)
Rejection and Tolerance (1994) (19)
Scintigraphy with J001X, a Klebsiella membrane glycolipid, for the early diagnosis of chronic berylliosis: results from an experimental model. (1992) (19)
Elevation of cyclic 3'5' adenosine monophosphate levels by cholera toxin inhibits the generation of interleukin 2 activity. (1986) (19)
Turnover studies of human beta 2-microglobulin in the rat: evidence for a beta 2-microglobulin-binding plasma protein. (1982) (19)
Modulation of polyclonally activated human peripheral B cells by aggregated IgG and by IgG-binding factors: differential effect on IgG subclass synthesis. (1984) (19)
Suppression of polyclonal human B cell activation by IgG binding factors: interference with the maturation of Ig-containing cells into Ig-secreting cells. (1984) (19)
A rosette technique for identification of human mononuclear cells bearing Fc receptors. (1975) (18)
In vitro functional properties of antithymocyte globulins: clues for new therapeutic applications? (1998) (18)
Complexes of α1-microglobulin and monomeric IgA in multiple myeloma and normal human sera (1985) (18)
Scintigraphy with J001 macrophage targeting glycolipopeptide. A new approach for sarcoidosis imaging. (1992) (18)
Long-term results in kidney transplantation: patient and graft survival, causes of graft failure and mortality, renal function and complications after 10 years. (1987) (18)
Cyclic AMP can enhance mouse B cell activation by regulating progression into the late G1/S phase (1989) (18)
Active and passive re‐expression of Fcγ receptors on human lymphocytes (1980) (18)
Effects of Anti-β2 microglobulin antibodies on human lymphocytes (1975) (17)
Immunologic alterations in chronic renal insufficiency. (1979) (17)
Specific hyporesponsiveness of alloreactive peripheral T cells induced by CD4 antibodies (1995) (17)
Requirement for tyrosine phosphorylation in lipopolysaccharide-induced murine B-cell proliferation. (1993) (17)
Acylation of the lipid A region of a Klebsiella pneumoniae LPS controls the alternative pathway activation of human complement. (1994) (17)
Pulmonary sarcoidosis: flow cytometry measurement of lung T cell activation. (1985) (17)
Immunologic properties of placental eluates. (1976) (17)
Phenotyping of 76 human bladder tumors with a panel of monoclonal antibodies: correlation between pathology, surface immunofluorescence and DNA content. (1989) (17)
Proteinuria in Human Renal Allografts—Sequential Studies (1970) (17)
Cytokines and Cytokine Receptors: Physiology and Pathological Disorders (2001) (16)
A noncomitogenic CD2R monoclonal antibody induces apoptosis of activated T cells by a CD95/CD95-L-dependent pathway. (1998) (16)
Immunosuppressive antimetabolites inhibit induction of contact hypersensitivity while lymphoablative drugs also prevent its expression. (2003) (16)
Apoptosis of activated peripheral T cells. (1999) (16)
Alterations in polymeric immunoglobulin receptor expression and secretory component levels in bladder carcinoma (2004) (16)
Studies of anti-lymphocyte globulins made from thoracic duct lymphocytes. (1969) (16)
Cancer in Transplantation: Prevention and Treatment (1996) (15)
Glutathione and HIV infection (1990) (15)
Detection of recurrent cytomegalovirus infection in renal-transplant patients. (1984) (15)
Purification of α1-microglobulin produced by human hepatoma cell lines (1987) (15)
Characterization of rat ?1 microglobulin (1983) (15)
PURIFICATION OF HLA ANTIGENS FROM URINE (1976) (15)
Human T lymphocytes expressing the C3b/C4b complement receptor type one (CR1, CD35) belong to Fc gamma receptor-positive CD4-positive T cells. (1989) (15)
Modulation of lymphocyte receptors for IgG inhibits responding cells in the mixed lymphocyte reaction. (1979) (15)
Serum secretory IgA and IgM and free secretory component in IgA nephropathy. (1995) (15)
Evaluation of bladder cancer with a miniature high frequency transurethral ultrasonography probe. (1987) (15)
Characterization of Monoclonal Antihuman‐B‐Cell Antibody BL13 as an Anti‐C3d‐Receptor (CR2) Antibody (1986) (14)
Renal tubular absorption of beta 2 microglobulin. (1984) (14)
Internalization and degradation of anti-CD4 monoclonal antibodies bound to human peripheral blood lymphocytes. (1993) (14)
Cell-mediated immunity: in vitro correlates, (1971) (14)
Study of human T and B lymphocytes with heterologous antisera. IV. Subpopulations in tonsil and adenoid cell suspensions. (1978) (14)
Polymeric Ig receptor expression in hepatocellular carcinoma. (1992) (14)
Auto-antibodies specific for β2 microglobulin in normal human serum (1983) (14)
[Immunology and allergy]. (2003) (14)
Transient secretory IgA deficiency in mice after cyclophosphamide treatment. (1991) (14)
Mycophenolate mofetil interferes with interferon γ production in T-cell activation models (2001) (14)
beta2-microglobulin in monitoring renal transplant function. (1979) (13)
Kinetics of 125I-beta 2-microglobulin turnover in dialyzed patients. (1992) (13)
Only Tα or Tγ cells can be triggered by IgG or IgA to suppress the production of the matching Ig class (1986) (13)
In vitro correlates of the acute toxic syndrome induced by some monoclonal antibodies: a rationale for the design of predictive tests. (1995) (13)
Late Graft Loss (1997) (13)
Expression of CRl and CR2 Complement Receptors following Epstein‐Barr Virus Infection of Burkitt's Lymphoma Cell Lines (1987) (13)
Tumor necrosis factor-alpha up-regulates Bcl-2 expression and decreases calcium-dependent apoptosis in human B cell lines. (1995) (13)
Anti-beta2-microglobulin lymphocytotoxic autoantibodies in systemic lupus erythematosus. (1979) (12)
CD4 monoclonal antibody administration in atopic dermatitis. (1997) (12)
Proteinuria in human renal allografts. (1969) (12)
Nonspecific increased serum levels of secretory component in lung tumors: relationship to the gene expression of the transmembrane receptor form. (1993) (12)
PERIPHERAL NERVE ALLOGRAFTS: I. DISTINCTIVE HISTOLOGICAL FEATURES OF NERVE DEGENERATION AND IMMUNOLOGICAL REJECTION (1979) (12)
Spontaneous expression of a low affinity Fc receptor for IgA (Fc alpha R) on human B cell lines. (1989) (12)
Human T lymphocyte receptors for IgM: control by IgG‐binding lymphocytes (1979) (12)
Monocyte-independent T-cell activation by polyclonal antithymocyte globulins. (1992) (12)
Lymphocyte subpopulations and mitogenic responses in nasopharyngeal carcinoma, prior to and after radiotherapy (1977) (12)
Secretory immunoglobulin A in hepatobiliary diseases. (1991) (11)
Autoantibodies (cold lymphocytotoxins, antiactin antibodies and antinuclear factors) in nasopharyngeal carcinoma patients. (1978) (11)
Immunosuppression in composite tissue allografts. (2001) (11)
Differential measurement by ELISA of free and IgA bound alpha1-microglobulin in human serum without prior fractionation. (1985) (11)
High serum levels of secretory component in hepatocellular carcinoma. (1988) (11)
Suppression of polyclonal B cell activation by IgG‐binding factors. Requirement for T cells (1985) (11)
Monocyte cytokine secretion induced by chemically‐defined derivatives of Klebsiella pneumoniae (1992) (11)
Evidence for T‐cell involvement during the acute phase of echo virus meningitis (1992) (11)
Mycophenolate mofetil interferes with interferon gamma production in T-cell activation models. (2001) (11)
Expression of the galactose binding protein Mac-2 by human melanoma cell-lines. (1994) (10)
Serum beta2-microglobulin in hemodialyzed patients. (1978) (10)
TNF-alpha production as an in vitro assay predictive of cytokine-mediated toxic reactions induced by monoclonal antibodies. (1995) (10)
Cryptosporidium parvum sporozoite staining by propidium iodide. (1992) (10)
Serum beta-2-microglobulin binding activity in monoclonal gammopathy: correlative study and clinical significance. (1983) (10)
Cyclic adenosine 3',5'-monophosphate response to dopamine in mouse lymphoid cells and cell lines. (1987) (10)
[Decrease of erythrocyte receptors for the C3b fragment of complement in acquired immunodeficiency syndrome]. (1988) (10)
CD4 mAbs prevent progression of alloactivated CD4+ T cells into the S phase of the cell cycle without interfering with early activation signals. (1996) (10)
In vitro assay of suppressive properties of antilymphocyte sera on lymphocyte stimulation. (1970) (10)
Plasma beta 2 microglobulin turnover in renal insufficiency. (1980) (10)
Characterization of molecules bearing HLA determinants in serum and urine. (1979) (9)
Elevation of cyclic adenosine monophosphate levels independently down regulates IL-1, IL-2, and IL-2 receptor (CD25) syntheses. (1990) (9)
IL-2-resistant hyporesponsiveness induced by CD4 mAbs in OKT3-activated human T cells is reversed by CD45RA triggering. (1996) (9)
Antibody response to horse gamma-globulin in recipients of renal allografts: relationship with transplant crises and transplant survival. (1977) (9)
(ATGs): a novel mechanism of T cell depletion Cathepsin B-dependent apoptosis triggered by antithymocyte globulins (2003) (9)
Contribution of beta-adrenoceptors to the dopamine-induced elevation of cyclic 3',5'-adenosine monophosphate levels in mouse lymphocytes. (1987) (9)
Serum and bile secretory immunoglobulins and secretory component during the early postoperative course after liver transplantation (1991) (9)
Serum levels of beta-2-microglobulin--a new marker of activity in Crohn's disease. (1979) (9)
Modification of lymphocyte DNA synthesis by α1-antitrypsin (1981) (9)
Localization of α1-microglobulin (HC protein) in normal human tissues: An immunohistochemical study using monoclonal antibodies (1984) (8)
Effects of alloantibodies on lymphocyte proliferation in vitro. (1973) (8)
Constitutive expression of Ia molecules by murine epithelial cells: a comparison between keratinocytes and enterocytes. (1990) (8)
Potential and Actual Clinical Applications of in vitro Tests for Cell-Mediated Immunity (1971) (8)
Oral administration of immunomodulators and the mucosal immune system. (1992) (8)
Serum levels and urinary excretion of beta 2 microglobulin in patients under haemodialysis or after renal transplantation. (1980) (8)
Clinical significance of beta 2 microglobulin determination. (2016) (8)
Activation of human monocyte chemiluminescence response by acylpoly(1,3)galactosides derived from Klebsiella pneumoniae (1992) (8)
Study of human T and B lymphocytes with heterologous antisera. II. Partial characterization of a human T lymphocyte antigen. (1976) (8)
Role of acyl residues in polyclonal murine B cell activation by acylpoly(1,3)galactosides from Klebsiella pneumoniae. (1993) (8)
Expression of receptors for iga on mitogen‐stimulated human t lymphocytes (1988) (8)
TNFα and CD95-L contribute to apoptosis of activated lymphocytes triggered by ATGs (1999) (8)
Mitogenic Response of Murine B Lymphocytes to Salmonella typhimurium Lipopolysaccharide Requires Protein Kinase C-Dependent Late Tyrosine Phosphorylations (1998) (8)
Binding of a Bacterial Acylpoly(1,3)Galactoside to Human Blood Leucocytes (1992) (8)
Contribution of lymphocytes bearing Fcgamma receptors to PHA-induced cytotoxicity. (1978) (8)
Induction of Murine B Cell Proliferation and Immunoglobulin Synthesis by Some Bacterial Ribosomes (1988) (8)
CD4 antibody therapy and cyclosporin A differentially affect HLA-DR and ICAM-1 expression in psoriatic skin. (1992) (8)
Intestinal secretory antibody response induced by an oral cholera vaccine in human volunteers. (1988) (8)
Second signal for T lymphocyte activation: multiple targets for pharmacological modulation. (1992) (8)
Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in the popliteal lymph node assay. II. Comparison with acute graft-vs-host reaction in H-2 incompatible F1 mouse hybrids. (1992) (8)
Purification of alpha 1-microglobulin produced by human hepatoma cell lines. Biochemical characterization and comparison with alpha 1-microglobulin synthesized by human hepatocytes. (1987) (7)
Guidelines for the PhD degree in immunology (1992) (7)
TNF alpha and CD95-L contribute to apoptosis of activated lymphocytes triggered by ATGs. (1999) (7)
Presence of HL-A antigens and beta2-microglobulin in tubular proteinuria. (1974) (7)
Heterogeneity of murine gut epithelium: three subsets defined by expression of dendritic cell markers. (1989) (7)
6-Methylprednisolone does not impair anti-thymocyte globulin (ATG) immunosuppressive activity in non-human primates. (2001) (7)
IL-5-induced IgA synthesis by LPS-stimulated mouse B cells is prevented by protein kinase C inhibitors. (1992) (7)
Selective induction of high levels of IgA synthesis in Peyer's patch B cells by protein kinase C-activating phorbol esters. (1991) (7)
Proteinuria in Glomerular Disease (1970) (7)
Alpha 1-microglobulin (HC protein) in human hepatocellular carcinoma. (1989) (7)
Immunohistological localization of alpha 1-microglobulin in normal rat tissues. (1984) (7)
Study of Urinary Proteins by Zone Electrophoresis (1970) (7)
[Fabry's disease: two patients improved by fetal liver cells (author's transl)]. (1979) (6)
Alpha 1-microglobulin: a new antigenic component of the epidermo-dermal junction in normal human skin. (1985) (6)
Identification of cell subpopulations by dual-color surface immunofluorescence using biotinylated and unlabeled monoclonal antibodies. (1988) (6)
Identification of High Affinity Calcitonin Gene–Related Peptide Receptors on a Murine Macrophage‐like Cell Line a (1990) (6)
Antibody-induced modulation of the leukocyte CD11b integrin prevents mild but not major renal ischaemic injury. (2000) (6)
Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines. (1987) (6)
Inhibition of human T cell response to staphylococcal enterotoxin B by prior ligation of surface CD4 molecules. (1993) (6)
Sequential changes in cytomegalovirus antigenic pattern during infection of renal transplant patients. (1986) (6)
Elevated C-Reactive Protein Levels in Sarcoidosis Patients (1982) (6)
Clinical improvement of a patient with severe psoriasis following CD4 antibody administration despite a blocking antibody-host response (1996) (6)
A rapid mechanical vibration procedure for purifying mature (Ia positive) columnar epithelial cells from the mouse small intestine. (1989) (6)
Sodium valproate does not alter immune competence in mice. (1989) (5)
Innate immunity. (2002) (5)
In vitro stimulation or inhibition of lymphocyte activation by antilymphocyte serum. (1971) (5)
Elevation of serum beta 2-microglobulin levels during infectious mononucleosis. (1982) (5)
Rapid binding of β2-microglobulin to renal brush-border membranes (1987) (5)
Cross-reactivity between immunoglobulins and β2 microglobulin (1980) (5)
Study of α1 Microglobulin (HC Protein) with Monoclonal Antibodies (1982) (5)
[Electron microscopic study of adenosine triphosphatase activity of cytoplasmic membranes of lymphocytes transformed in vitro]. (1967) (5)
Elevation of 3'5' cyclic adenosine monophosphate alters CD3 and CD25 antigens expression in activated T lymphocytes. (1989) (4)
Localization of alpha 1-microglobulin (HC protein) in normal human tissues: an immunohistochemical study using monoclonal antibodies. (1984) (4)
Proliferative response of human T lymphocytes to a vaccinal preparation of ribosomes from Streptococcus pyogenes. (1988) (4)
[Evaluation of serum beta 2-microglobulin levels in immunologically mediated liver disease]. (1982) (4)
Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity. (1981) (4)
Secretory immunoglobulins in serum from human immunodeficiency virus (HIV)-infected patients (1992) (4)
Free secretory component in human serum. (1988) (4)
Up-regulation of receptors for IgA on activated human B lymphocytes. (1988) (4)
Charge heterogeneity of β2-microglobulin in lymphoid cells (1989) (4)
Some Viral Infections and Related Disorders Associated with Long-term Immunosuppressive Treatments (1988) (4)
Class‐specific suppression of human b cell maturation by iga‐binding factors (1988) (4)
Interleukin-10 as a key regulator of inflammation and stress responses (2000) (4)
Cold lymphocytotoxic antibodies in nasopharyngeal carcinoma. (1977) (4)
Selective deficiency of cell-mediated immunity in humans treated with antilymphocytes globulins. (1971) (3)
Modification of lymphocyte DNA synthesis by alpha 1-antitrypsin. (1981) (3)
Significance of beta 2-microglobulin in liver diseases. (1980) (3)
[Lymphocyte cultures]. (1971) (3)
Ultrastructural identification of human tonsil T-lymphocytes by peroxidase-conjugated anti-HTLA serum (1976) (3)
Modulation of Pokeweed Mitogen‐Induced Human B‐Cell Differentiation by Aggregated IgG (1984) (3)
T-cells and immunoglobulin-binding factors in the isotypic regulation of polyclonally activated human B lymphocytes (1985) (3)
[Secondary deficiencies of humoral immunity]. (1991) (3)
Elevation of serum beta 2 microglobulin in liver diseases. (1981) (3)
Catecholamine Regulation of Mouse B Cell Activation. Functional Dichotomy between LPS and Anti‐immunoglobulin Antibody Responses (1990) (3)
Auto-antibodies specific for lymphocyte surface antigens--a review. (1980) (3)
Beta 2-microglobulin-associated amyloidosis in chronic haemodialysis patients. (1986) (3)
Flow cytometric demonstration of shared antigens between human bladder cancer cells and normal host macrophages. (1989) (3)
Interaction between α1 antitrypsin and lymphocyte surface proteases: immunoregulatory effects (1981) (3)
Induction of mouse IgA B cell differentiation by phorbol ester in the absence of proliferation. (1993) (3)
[125I] Clq-binding activity and its relationship with anti-Epstein--Barr virus antibodies in sera from nasopharyngeal carcinoma patients. (1979) (3)
Flow Cytometry Assessment of Local T Cell Activation in Hypersensitivity Pneumonitis a (1986) (3)
[Technic, surveillance and value of the drainage of the thoracic duct, executed in view of a renal transplantation]. (1969) (3)
Modulation of cell-mediated lympholysis by alloantisera. (1973) (3)
Binding to leukocytes and induction of TNF alpha production involve different sites within the lipid-A region of LPS-like molecules. (1994) (3)
Sarcoidosic alveolitis: a classification based on flow cytometric studies of T lymphocyte activation. (1983) (3)
CD4 antibody therapy in chronic inflammatory dermatological diseases. (1993) (3)
[Alteration of beta2-microglobulin metabolism in terminal chronic renal insufficiency (author's transl)]. (1978) (3)
Characterization of Langerhans' cells using a monoclonal anti-HLA-DR (Ia-like) antibody. (1981) (3)
Renal brush border membrane binding of beta 2-microglobulin is rapid, saturable and inhibited by albumin. (1988) (2)
Distribution of Ig Classes and IgG Subclasses among Human B Cells Activated by Nocardia opaca‐Delipidated Cell Mitogen or by Pokeweed Mitogen (1985) (2)
[Letter: Coxsackie B virus infections in kidney transplantation]. (1976) (2)
Cytotoxic and proliferative responses of human thoracic duct lymphocytes: effect of thoracic duct drainage in uremic patients. (1976) (2)
Cell surface protease activity of human lymphocytes; its inhibition by α 1-antitrypsin (1981) (2)
Use of leukocytes infiltrating bladder tumors as an internal reference for determining the DNA index by flow cytometry. (1991) (2)
Iatrogenic immunodeficiencies. (1992) (2)
The search for disease susceptibility genes. Medical and ethical problems of predictive medicine. (1999) (2)
Alpha 1-microglobulin (HC protein) and its IgA complex in human secretory fluids. (1987) (2)
Polypeptides and major antigens of four new isolates of cytomegalovirus (2005) (2)
Antibody‐Dependent Cell Cytotoxicity (ADCC) (1976) (2)
Anti-Ia antibodies in therapy. (1984) (2)
Production of human antilymphocytic serum in horse with thoracic duct lymphocytes and peripheral blood lymphocytes. (1970) (2)
Fc receptor-bearing T cells and Ig binding factors as class-specific suppressors of polyclonally activated human B cells. (1987) (2)
CD4, CD8, and other surface molecules regulating T-cell activation. (1993) (2)
[The plasma turnover of 125I beta 2 microglobulin in healthy humans and patients with renal insufficiency (author's transl)]. (1980) (2)
Alveolar Lymphocyte Activation during Sarcoidosis a (1986) (2)
Competition between albumin and beta-2-microglobulin for renal tubular uptake: brush border and/or lysosomes? (1988) (2)
[Immune deficits in hemodialysis patients]. (1990) (2)
[Drainage of the thoracic duct before transplantation in patients with chronic renal insufficiency]. (1968) (2)
Complexes of alpha 1-microglobulin and monomeric IgA in multiple myeloma and normal human sera. (1985) (2)
Isolation of Fcγ Receptors Released by Human Lymphocytes (1982) (2)
Characterization of polyclonal autoantibodies specific for beta 2-microglobulin in multiple myeloma sera. (1983) (2)
[Immunological aspects of interactions between mother and foetus (author's transl)]. (1979) (2)
HETEROGENEITY OF HUMAN LYMPHOID CELLS BINDING THE Fc REGION OF IgG (1976) (2)
Antilymphocyte globulins in kidney transplantation: effects on glomerular disease. (1969) (2)
[Mechanisms of autoimmunity and therapeutic implications]. (2001) (2)
Endocytosis of class II histocompatibility antigens and formation of intracytoplasmic granules at the final differentiation stage of human B lymphocytes. (1983) (2)
Free secretory component (SC) and secretory IgA (S-IgA) in human serum. (1987) (2)
Human migration inhibition factor: a preliminary report. (1972) (1)
Effect of some immunosuppressive agents on blastogenesis and target-cell lysis in vitro. (1973) (1)
[Determination of circulating immune complexes: comparison between agglutination inhibition and C1Q precipitation in polyethylene-glycol-EDTA (author's transl)]. (1978) (1)
Cell surface protease activity of human lymphocytes; its inhibition by alpha 1-antitrypsin. (1981) (1)
TRANSPLANTATION AND CLINICAL IMMUNOLOGY VOLUME XXII (1991) (1)
Improvement of cadaveric renal allograft survival by thoracic duct drainage: relation with T-lymphocyte subset modifications assessed by flow-cytometry. (1983) (1)
Circulating antibodies in allograft recipients. (1975) (1)
Alteration of membrane phospholipid methylation by adenosine analogs does not affect T lymphocyte activation. (1990) (1)
[Case of cardiac transplantation for fully developed myocardiopathy]. (1969) (1)
Interaction between alpha 1 antitrypsin and lymphocyte surface proteases: immunoregulatory effects. (1981) (1)
414 Distribution 0f androgen and estrogen receptors among human peripheral T lymphocyte subsets (1983) (1)
Flow cytometry analysis of leucocytes infiltrating bladder tumours according to grade and urothelial cell DNA content. (1989) (1)
Apoptosis, tolerance and immunoregulation - Integrated pathways for immune system homeostasis (1998) (1)
Nephrotoxicity of Iodinated Contrast Media: A Preliminary Report on Five Compounds Used for Urography (1982) (1)
[Study of lymphocyte membrane antigens and receptors with antibodies to beta2-microglobulin (author's transl)]. (1978) (1)
IgG-binding factors and polyclonal activation of human B cells (1983) (1)
Inhibition of neutrophil-mediated cytotoxicity by alpha 2 macroglobulin. (1980) (1)
Characterization of rat alpha 1 microglobulin. (1983) (1)
[Electrophoretic study of proteinuria in 31 Croat patients living in a country of endemic nephropathy]. (1968) (1)
Antigenic polypeptides of 3 reference strains recognized by sera from cytomegalovirus (CMV) infected patients. (1982) (1)
Prevention of chronic rejection and puromycin-induced glomerulosclerosis in rats by gamma-lactone, an inhibitor of macrophage-effector activation. (1996) (1)
[Serum beta 2 microglobulin levels in hemophiliacs in relation to the origin of injected blood products]. (1984) (1)
Guidelines for the PhD degree in immunology. International Union of Immunological Societies Education Committee. (1992) (1)
Antimacaque thymocyte globulins. Toxicity and immunodepressive effect in the human species. (1974) (1)
Anatomical distribution of T and B lymphocytes in human spleen, lymph node and tonsils. (1976) (1)
Active and passive re-expression of Fc gamma receptors on human lymphocytes. (1980) (1)
Immunosuppression in composite tissue transplantation (1999) (1)
Heterogeneity of DNA index in renal-cell carcinoma. (1990) (1)
Auto-antibodies specific for beta 2 microglobulin in normal human serum. (1983) (1)
[Cellular targets of immunoglobulins eluted from the placenta]. (1988) (1)
[Therapeutic prospects in autoimmunity]. (1994) (1)
[Beta 2 microglobulin in pathology. Introduction]. (1978) (1)
[Presence of glycoproteins binding human beta 2 microglobulin in rat serum]. (1981) (1)
In vitro cell activating properties of the composite ribosomal vaccine D53 (1987) (1)
[Criteria for T-lymphocyte activation in alveolitis]. (1983) (1)
Cross-reactivity between immunoglobulins and beta 2 microglobulin. (1980) (0)
[Perspectives of application of anti-CD4 antibodies in the treatment of autoimmune diseases]. (1994) (0)
[Ultrastructural identifaction of human T lymphocytes using a peroxidase-conjugated anti-HTLA serum]. (1977) (0)
Inhibition of neutrophil-mediated cytotoxicity by α2 macroglobulin (1980) (0)
[Electrophoretic analysis of proteinurias encountered in the course of renal tubular disorders]. (1965) (0)
[Asymptomatic acquired immunological deficiencies. Nosologic and therapeutic problems]. (1984) (0)
[The interaction of cellular immunity and of viral factors in the pathogenesis and the resolution of HB virus infections in hemodialysis (author's transl)]. (1980) (0)
The suppression activity of Fc gamma receptors is not related to their T-cell origin. (1982) (0)
[Immunology of pregnancy. II. Control and pathology of the maternal immune response (author's transl)]. (1977) (0)
Turnover studies of labeled beta 2 microglobulin in hemodialyzed patients 1 kinetics of beta 2 m during dialysis (1990) (0)
In vivo Antigenic Modulation of CD5+ Cells in Renal Transplanted Patients Receiving Anti-CD5 Antibody Infusions (1988) (0)
Only T alpha or T gamma cells can be triggered by IgG or IgA to suppress the production of the matching Ig class. (1986) (0)
Title Page / Contributors / Contents / Abbreviations / Acknowledgements (1971) (0)
Thymidine deprivation by thymidylate synthase inhibition triggers apoptosis of activated peripheral T cells in the S phase of the cell cycle (1999) (0)
Galectin-3, a new LPS binding protein with two functional sites (1995) (0)
[Prognostic value of delayed-hypersensitivity skin tests and rosette studies in acute non-lymphoid leukemias]. (1978) (0)
Circulating immune complexes in renal transplanted patients. (1979) (0)
[Value of 2 monoclonal antibodies in the diagnosis of tumors of the uterine cervix]. (1986) (0)
Engagement of HLA class I α1 domain induces apoptosis of activated CD45RA+ T cells (1997) (0)
[Kidney transplantation at the age of 2 years and 4 months for congenital nephrotic syndrome]. (1976) (0)
Déficit en lymphocytes T CD4 (OKT4+) après drainage du canal thoracique (1985) (0)
COLD LYMPHOCYTOTOXIC ANTIBODIESIN NASOPHARYNGEAL CARCINOMA (1977) (0)
[Human lymphocyte receptors for the Fc ends of IgG]. (1980) (0)
Charge heterogeneity of beta 2-microglobulin in lymphoid cells. (1989) (0)
[Immunosuppression by means of antilymphocyte serums in humans]. (1972) (0)
Murine gut epithelial cells present antigen to specific T cell hybridoma (1990) (0)
[Renal excretion of iron and proteinuria]. (1967) (0)
[Newborn lymphocyte cultures: stimulation with phytohemagglutinin]. (1970) (0)
[Semiological value of electrophoretic analysis of urinary proteins]. (1967) (0)
Role of Cell Surface Molecules in T Cell Triggering (1985) (0)
FLOW CYTOMETRY: A TOOL FOR TOXOPLASMOSIS DIAGNOSIS (1991) (0)
[Diagnostic value of flow cytometry of bladder lavage in the surveillance of bladder tumors]. (1987) (0)
[Selective proteinurias]. (1967) (0)
Super-Avidin-Biotin System for Detecting Low-Density Cell Surface Antigens by Flow Cytometry (1989) (0)
[Regulation of immunoglobulin production: role of the cellular receptors for the Fc portion of these molecules]. (1982) (0)
A Possible Mechanism of High Dose Supraoptimal Activation of T Lymphocytes : Cathepsin-Dependent Apoptosis Triggered (2004) (0)
125 Phospholipid methylation and lymphocyte activation (1988) (0)
[Autoimmunity: a concept generating therapeutic tools]. (1996) (0)
[Immunology of pregnancy. I.--Mother's immunization against her fetus (author's transl)]. (1977) (0)
The immune system as a target for chemical toxicity. (1991) (0)
[The role of T cells in defense against infection]. (1988) (0)
Aspects immulogiques du Syndrome de Fatigue Chronique (1991) (0)
in Normal Rat Tissues (2011) (0)
Index of Participants to the Discussions / Subject Index (1971) (0)
Fate of antibodies bound to lymphocyte surface. II.--Degradation and release of immune complexes. (1976) (0)
[Cultures of lymphocytes under iterative injections of BCG in leukemic children with remission]. (1970) (0)
[HL-A antigens and beta-2-microglobulin in urine]. (1974) (0)
Human B Lymphocytes 1 Domain Trigger Apoptosis of CD40-Activated α Antibodies to HLA Class I (2013) (0)
Mature la+ murine intestinal epithelial cells with APC activity share common antigens with gut interdigitating dendritic cells (1990) (0)
Overall evaluation of immunomodulators. (1992) (0)
Scintigraphy withJOOlMacrophage Targeting Glycolipopeptide* A NewApproachfor Sarcoidosis Imaging (2017) (0)
Identification of shared antigenic determinants of different polypeptides from Davis and Towne cytomegalovirus strains with monoclonal antibodies (2005) (0)
Effects of anti-beta-2 microglobulin antibodies on human lymphocytes. (1975) (0)
Retransplantation : proceedings of the 29th Conference on Transplantation and Clinical Immunology, 9-11 June, 1997 (1997) (0)
CD 95 / CD 95-L-Dependent Pathway Induces Apoptosis of Activated T Cells by a A Noncomitogenic CD 2 R Monoclonal Antibody Bismuth (1998) (0)
Mucosal immunity : IgA and polymorphonuclear neutrophils (1985) (0)
[Current concepts of cellular immunology]. (1980) (0)
Binding of Alpha-l-Antitrypsin Specific Antibodies to Human Lymphocytes: A Flow Cell Microfluorometry Study (1982) (0)
Rat Serum Components with Affinity for Human B2 Microglobulin (1982) (0)
[Therapeutic management of chronic renal failure]. (1973) (0)
Fate of antibodies bound to lymphocyte surface. I.--Study with complement-dependent cytotoxicity, indirect immunofluorescence and radiolabelled antibodies. (1976) (0)
Cyclic AMP Response to Dopamine in the Human Monocyte-Like Cell Line U-937 (1988) (0)
[Semeiological value of the electrophoretic analysis of urinary proteins]. (1967) (0)
[Future prospects of immunosuppressive treatment]. (1987) (0)
The Immune System: An Integrated Overview (1990) (0)
flow-cytometry study . rheumatoid arthritis : a content of synovial fluid cells in Increased DNA and / or RNA (0)
[The cells of Waldeyer's ring: structural study, surface makers and responses in vitro]. (1979) (0)
[Interruption of the lymphatic drainage pathways and pancreatitis. Anatomoclinical correlations between clamping of the thoracic duct and the occurrence of acute pancreatitis]. (1982) (0)
Questions raised by the exclusion of ‘at risk’ conditions from current trials in organ transplantation (1999) (0)
[Recent data on Gougerot-Sjögren syndromes]. (1981) (0)
[Fc receptors and immunomodulating effects of immunoglobulins. In vitro study]. (1983) (0)
[Cytofluorometric study of the cell cycle and various lymphocyte differentiation membrane antigens in the synovial fluid in rheumatoid polyarthritis]. (1984) (0)
[Immunointervention in psoriasis. Pathogenic consequences]. (1993) (0)
Survival and Sensitization to Apoptosis T Cell Proliferation, But Not IL-2-Dependent Mycophenolic Acid Inhibits IL-2-Dependent (2002) (0)
Contents, Vol. 86, 1988 (1988) (0)
Pharmacokinetics of antithymocyte globulins : effects of low dose vs high dose of Thymoglobuline® in a non human primate model. (1999) (0)
Book Reviews / Books Received (1987) (0)
[Recent advances in physiopathology of autoimmune diseases and their therapeutic implications]. (1993) (0)
Monitoring of renal transplant damage by determination of serum c reactive protein levels a new approach to the classification of transplant crises (1981) (0)
The agonizing by lymphoblast (1992) (0)
[Lymphomatoid granulomatosis and hypersensitivity pneumopathy. Clinical and biological study (serum and alveolar) toward a new pathogenic hypothesis of the disease]. (1983) (0)
[Cellular immunity deficiency secondary to a kidney failure]. (1970) (0)
Suppression of Antibody-Dependent Lymphocyte Mediated Cytotoxicity by Human Alpha-2 Macrogobulin (1982) (0)
[Application of cutaneous tests of delayed hypersensitivity to the study of cellular immunity deficiencies]. (1970) (0)
Role for protein kinase C activation in IgA B cell terminal differentiation (1991) (0)
Expression of the galactose binding protein melanoma cell-lines (1994) (0)
[Electrophoretic analysis of the proteinuria of glomerulonephritis and the nephrotic syndrome]. (1965) (0)
Binding of alpha 1 antitrypsin (alpha 1 protease inhibitor) to human lymphocytes. (1981) (0)
[Inhibition of guinea pig peritoneal migration human lymphocytes stimulated with antilymphocyte serum]. (1971) (0)
[Problems raised by the creation of a "nephrologic data bank" on a computer]. (1971) (0)
Increased HLA-DR antigen expression in human hepatocytes after liver transplantation: kinetic analysis using fine needle aspiration biopsy. (1988) (0)
Induction of human monocyte chemiluminescence response by an acylated peptidopolygalactose (APPG) from Klebsiella pneumoniae: A role for complement receptor type three (CR3, CD11b/CD18) (1991) (0)
[International refresher course on organ transplantation. Lyon (25-28 May)]. (1970) (0)
Spanning innate and adaptive immunity: a role for interleukin-18 (2001) (0)
[Immunological aspects of corticotherapy]. (1976) (0)
[T CD4(OKT4+) lymphocyte deficiency after thoracic duct drainage]. (1985) (0)
[Proteinuria in the idiopathic nephrotic syndrome of childhood (Electrophoretic study)]. (1967) (0)
Interaction Between Immune Complexes and Lymphocyte Fcγ Receptors (1981) (0)
[Antilymphocyte serum: choice of antigen for its preparation and immunosuppression tests]. (1969) (0)
Alteration of deacylated lipopolysaccharide antagonistic properties by interaction with plasma factors (1997) (0)
Folate analogues accelerate T cell deletion but do not prevent anergy following staphylococcal enterotoxin B administration in mice (1999) (0)
Immunological rationale for induction therapy in patients with donor-specific memory T cells (1997) (0)
ARE MLR-R AND MLR-S GENE PRODUCTS EXPRESSED ON TWO DIFFERENT CELL TYPES? (1976) (0)
Immunoglobulin secretion by Burkitt's lymphoma cell lines. (1984) (0)
atopic dermatitis antibo@ administration in (1997) (0)
Molecular variants of /-microglobulin in renal insufficiency (2005) (0)
[Drainage of the thoracic canal in men before renal transplantation: technic, surveillance and results]. (1969) (0)
Suppression of human IgA-B-cell maturation by IgA-binding factors requires T cells. (1988) (0)
Iatrogenic immunodeficiencies. (1989) (0)
LymphocytesDuring Apoptosis of Primary T Caspase-Independent Phosphatidylserine (2013) (0)
Serum C-Reactive Protein Assay in Renal Transplantation (1982) (0)
[Proceedings: Human B and T lymphocytes in the mixed lymphocyte reaction]. (1975) (0)
[Proceedings: "Natural" lymphocytotoxic antibodies in autoimmune Swan mice and in thymectomized mice]. (1975) (0)
[Markers of lymphocyte activation in interstitial pulmonary disease]. (1983) (0)
[A micromethod for culture of human lymphocytes: technic and interpretation]. (1972) (0)
[Plasma concentrations and urinary excretion of beta2 microglobulin after renal transplantation (author's transl)]. (1978) (0)
[Biology of Listeria infections. Effect of immunodepression]. (1972) (0)
[The disappearance curve of horse antilymphocyte globulins labeled with I-131 and I-125 in long term treatment of posttransplantation patients]. (1972) (0)
Rapid binding of beta 2-microglobulin to renal brush-border membranes. (1987) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jean‐pierre Revillard?

Jean‐pierre Revillard is affiliated with the following schools:

University of Oxford